DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Apothecon Pharmaceuticals Pvt Ltd
03 1Aurobindo Pharma Limited
04 1F.I.S. Fabbrica Italiana Sintetici S.P.A.
05 1Glenmark Life Sciences Limited
06 1Hetero Drugs Limited
07 1Lianyungang Runzhong Pharmaceutical Co., Ltd.
08 1MAHI DRUGS PRIVATE LIMITED
09 1MSN Laboratories Private Limited
10 1Patheon Manufacturing Services LLC
11 1Piramal Pharma Limited
12 1ScinoPharm Taiwan Ltd.
13 1Wisdom Pharmaceutical Co.,Ltd
01 1FOSAPREPITANT DIMEGLUMINE
02 1Forsaprepitant Dimeglumine
03 10Fosaprepitant Dimeglumine
04 1Fosaprepitant dimeglumine
01 2China
02 6India
03 1Italy
04 1Taiwan
05 2U.S.A
06 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-038
Start Marketing Date : 2023-03-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-111
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52133-0045
Start Marketing Date : 2010-11-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0080
Start Marketing Date : 2008-01-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61662-0007
Start Marketing Date : 2015-08-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0064
Start Marketing Date : 2011-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63552-011
Start Marketing Date : 2008-01-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (150mg/5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 65085-0060
Start Marketing Date : 2016-09-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1322
Start Marketing Date : 2021-02-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13612-0026
Start Marketing Date : 2024-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Fosaprepitant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosaprepitant, including repackagers and relabelers. The FDA regulates Fosaprepitant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosaprepitant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fosaprepitant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fosaprepitant supplier is an individual or a company that provides Fosaprepitant active pharmaceutical ingredient (API) or Fosaprepitant finished formulations upon request. The Fosaprepitant suppliers may include Fosaprepitant API manufacturers, exporters, distributors and traders.
click here to find a list of Fosaprepitant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fosaprepitant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fosaprepitant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fosaprepitant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fosaprepitant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fosaprepitant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fosaprepitant suppliers with NDC on PharmaCompass.
We have 12 companies offering Fosaprepitant
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
